Abstract:Abstract Background Aberrant activation of the Hedgehog (Hh) signaling pathway is frequently observed in hepatocellular carcinoma (HCC), nevertheless, the precise molecular mechanism remains unclear. Forkhead box M1 (FOXM1), a target of the Hh pathway, is a key oncofetal transcription factor and a master cell cycle regulator. Targeting protein for Xenopus kinesin-like protein 2 (TPX2) is an oncogene critical for mitosis. However, how these molecular events affect HCC progression remains unclear. Methods Realtime PCR, immunohistochemistry, western blotting, and analyses of datasets TCGA and Gene Expression Omnibus (GEO) were conducted to assess the expression of TPX2 and FOXM1 at the mRNA and protein levels in HCC samples or HCC cells. Expression and knockdown of TPX2 and FOXM1 were performed to assess their role in regulating HCC cell proliferation in vitro and in vivo. Dual luciferase report assay and chromosome immunoprecipitation (ChIP) were investigated to seek the FOXM1 binding sites in the promoter of TPX2. Results Specific antagonists (cyclopamine and GANT61) of the Hh pathway down-regulated TPX2, whereas activation of Hh signaling stimulated TPX2 expression. Furthermore, TPX2 over-expression accelerated HCC cell proliferation when upstream events of Hh signaling were inhibited, and TPX2 knockdown significantly alleviated Sonic Hh ligand (Shh)-induced HCC cell proliferation. Reporter assays and ChIP showed that FOXM1 bound to the TPX2 promoter, confirming that TPX2 is a direct downstream target of FOXM1. Xenograft model further verified the cell function and expression regulation of TPX2 and FOXM1 in vivo. Furthermore, FOXM1 regulated TPX2 activity to drive HCC proliferation. Immunohistochemical (IHC) analysis indicated that FOXM1 and TPX2 were highly-expressed in HCC samples and cohort study revealed that FOXM1 and TPX2 may act as negative predictors for the prognosis of patients with HCC. Conclusions TPX2 acts as a novel downstream target and effector of the Hh pathway, and Hh signaling contributes to HCC proliferation via regulating the FOXM1-TPX2 cascade, suggesting that this signaling axis may be a novel therapeutic target for HCC. Graphical abstract

TPX2 Knockdown Suppressed Hepatocellular Carcinoma Cell Invasion Via Inactivating AKT Signaling and Inhibiting MMP2 and MMP9 Expression.

TPX2 as a novel prognostic biomarker for hepatocellular carcinoma.

TPX2 promotes migration and invasion of human breast cancer cells

Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.

Targeting TPX2 Suppresses Proliferation and Promotes Apoptosis Via Repression of the PI3k/AKT/P21 Signaling Pathway and Activation of P53 Pathway in Breast Cancer

Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma

TPX2 Level Correlates with Cholangiocarcinoma Cell Proliferation, Apoptosis, and EMT.

TPX2 Enhances the Transcription Factor Activation of PXR and Enhances the Resistance of Hepatocellular Carcinoma Cells to Antitumor Drugs

Tpx2 Regulates Tumor Growth in Human Cervical Carcinoma Cells

TPX 2 in Human Clear Cell Renal Carcinoma : Expression , Function and Prognostic Significance

Overexpressed Targeting Protein for Xklp2 (TPX2) Serves As a Promising Prognostic Marker and Therapeutic Target for Gastric Cancer.

The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation

CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis

TPX2 Promotes Glioma Cell Proliferation and Invasion Via Activation of the AKT Signaling Pathway.

Targeting Protein for Xenopus Kinesin-Like Protein 2 Knockdown Enhances Radiation Sensitivity of Human Lung Squamous Carcinoma Cell

Expression of targeting protein for xenopus kinesin-like protein 2 in cholangiocarcinoma and its clinical significance

Tpx2 is A Novel Prognostic Marker for the Growth and Metastasis of Colon Cancer

Investigation of the expression of TPX2 in tongue squamous cell carcinoma and its effect on Cal27 cell prolifer-ation and apoptosis

Validation of TPX2 As a Novel Prognostic Marker for Malignant Progression and Metastasis of Colon Cancer.

TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy

Overexpression of TPX2 is Associated with Progression and Prognosis of Prostate Cancer